Highlights Newsletter 1
This newsletter presents you the following key sessions:
1. PODCAST Javier Cortes about the KEYNOTE-355 trial
2. The clinical impact of COVID-19 on cancer patients
3. Frontline pembrolizumab significantly delays the disease progression of patients with metastatic colorectal
cancer and a high microsatellite instability
4. Smoking cessation and lung cancer outcomes: it is never too late to quit smoking
5. Maintenance olaparib prolongs the overall survival of women with platinum-sensitive relapsed ovarian
cancer harbouring a BRCA mutation by over 1 year
Please consult the prescribing information before prescribing via https://www.famhp.be/en